DAB2IP and hepatocellular carcinoma: More importantly, in our rescue experiments, we demonstrated that the overexpression of DAB2IP significantly mitigated the effects of the tRF‐34‐P4R8YP9LON4VHM mimics on the HCC cells proliferation, migration, invasion, and tumour cell‐induced angiogenic properties.